Severe hypertension after initiation of rifapentine/isoniazid for latent tuberculosis in renal transplant candidates. 2017

Jacques Simkins, and Michele I Morris, and Lilian M Abbo, and Jose F Camargo
Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

Jacques Simkins, and Michele I Morris, and Lilian M Abbo, and Jose F Camargo
June 2017, Infection,
Jacques Simkins, and Michele I Morris, and Lilian M Abbo, and Jose F Camargo
January 2014, Transplantation,
Jacques Simkins, and Michele I Morris, and Lilian M Abbo, and Jose F Camargo
April 2012, The New England journal of medicine,
Jacques Simkins, and Michele I Morris, and Lilian M Abbo, and Jose F Camargo
April 2012, The New England journal of medicine,
Jacques Simkins, and Michele I Morris, and Lilian M Abbo, and Jose F Camargo
April 2012, The New England journal of medicine,
Jacques Simkins, and Michele I Morris, and Lilian M Abbo, and Jose F Camargo
October 2012, Transplantation proceedings,
Jacques Simkins, and Michele I Morris, and Lilian M Abbo, and Jose F Camargo
December 2011, The New England journal of medicine,
Jacques Simkins, and Michele I Morris, and Lilian M Abbo, and Jose F Camargo
January 2015, Revista da Sociedade Brasileira de Medicina Tropical,
Jacques Simkins, and Michele I Morris, and Lilian M Abbo, and Jose F Camargo
August 2018, American journal of preventive medicine,
Jacques Simkins, and Michele I Morris, and Lilian M Abbo, and Jose F Camargo
April 2006, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!